Polumiros Inc. is an early-stage company founded based on innovative research at the University of Toronto, specializing in the development of novel immunomodulatory polymer technology. Polumiros Inc.’s primary focus is on the development of biocompatible amino acid-derived polymers in the form of medical device coatings, tissue regeneration scaffolds, and drug carriers that reduce biomedical implant-associated inflammation and fibrosis while enhancing biointegration and device functionality.